Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001641172-25-015482
Filing Date
2025-06-18
Accepted
2025-06-17 20:12:38
Documents
25

Document Format Files

Seq Description Document Type Size
1 forms-1.htm S-1 691479
2 EX-1.1 ex1-1.htm EX-1.1 351505
3 EX-5.1 ex5-1.htm EX-5.1 18484
4 EX-10.26 ex10-26.htm EX-10.26 135112
5 EX-10.27 ex10-27.htm EX-10.27 37836
6 EX-10.28 ex10-28.htm EX-10.28 111764
7 EX-23.1 ex23-1.htm EX-23.1 3772
8 EX-99.1 ex99-1.htm EX-99.1 4372
9 CALCULATION OF FILING FEE TABLE ex107.htm   iXBRL EX-FILING FEES 39632
10 GRAPHIC ex5-1_001.jpg GRAPHIC 16772
11 GRAPHIC ex5-1_002.jpg GRAPHIC 4679
12 GRAPHIC forms-1_001.jpg GRAPHIC 12427
13 GRAPHIC forms-1_002.jpg GRAPHIC 19299
14 GRAPHIC forms-1_003.jpg GRAPHIC 21135
15 GRAPHIC forms-1_004.jpg GRAPHIC 17913
  Complete submission text file 0001641172-25-015482.txt   1658733

Data Files

Seq Description Document Type Size
28 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 10230
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-288120 | Film No.: 251054864
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)